Mycosis fungoides responding to systemic itraconazole
Authors:
- 27 August 2003
- journal article
- case report
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 17 (5) , 588-590
Abstract
Mycosis fungoides is a form of cutaneous lymphoma with a typically indolent course. We describe an unexpected, repeated response to a systemic antifungal agent, itraconazole. The mechanism of action is speculative but itraconazole has marked immunosuppressive activity on T‐lymphocyte proliferation in vitro.Keywords
This publication has 10 references indexed in Scilit:
- Mycosis Fungoides With CD30-Positive Cells in the EpidermisThe American Journal of Dermatopathology, 2000
- How Useful Are T-Cell Receptor Gene Rearrangement Studies as an Adjunct to the Histopathologic Diagnosis of Mycosis Fungoides?The American Journal of Dermatopathology, 1999
- Anti‐inflammatory activity of antifungal preparationsInternational Journal of Dermatology, 1997
- Helicobacter pylori-associated gastritis and primary B-cell gastric lymphomaThe Lancet, 1991
- Mycosis Fungoides in Relation to Environmental Exposures and Immune Response: A Case-Control StudyJNCI: Journal of the National Cancer Institute, 1989
- A case-control study of possible causative factors in mycosis fungoidesArchives of Dermatology, 1987
- Mycosis fungoides responding to tetracycline and griseofulvinBritish Journal of Dermatology, 1981
- Demethylchlortetracycline and griseofulvin as examples of specific treatment for mycosis fungoidesBritish Journal of Dermatology, 1981
- Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factorCancer, 1980
- Mycosis fungoides—a disease of antigen persistenceBritish Journal of Dermatology, 1974